ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,572Medicare Part D Prescriptions Filled, Including Refills

Rank: 140 out of 1269

$513K Total Retail Price of All Prescriptions

Rank: 147 out of 1269

495 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 495 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 495 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 5,577 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
AMLODIPINE BESYLATE 402 316 1 2
LISINOPRIL 303 185 2 1
ATORVASTATIN CALCIUM 279 226 3 7
SIMVASTATIN 227 183 4 3
FUROSEMIDE 199 143 5 5
METOPROLOL SUCCINATE 195 151 6 13
HYDROCHLOROTHIAZIDE 190 112 7 10
METOPROLOL TARTRATE 184 148 8 6
LOSARTAN-HYDROCHLOROTHIAZIDE 177 147 9 59
LEVOTHYROXINE SODIUM 175 147 10 4
METFORMIN HCL 173 146 11 9
OMEPRAZOLE 153 123 12 8
PANTOPRAZOLE SODIUM 153 110 12 18
TRAMADOL HCL 149 93 14 16
PRAVASTATIN SODIUM 146 117 15 11
ATENOLOL 135 95 16 14
HYDROCODONE-ACETAMINOPHEN 128 89 S3 17 20
ZOLPIDEM TARTRATE 121 78 18 19
CRESTOR 109 102 19 25
CARVEDILOL 108 76 20 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 99 74 21 33
LOSARTAN POTASSIUM 97 91 22 15
AZITHROMYCIN 95 63 23 42
OXYCODONE HCL 83 41 S2 24 34
CLOPIDOGREL 80 49 25 32
GLIPIZIDE ER 70 58 26 102
OXYCODONE-ACETAMINOPHEN 68 41 S2 27 44
SERTRALINE HCL 68 53 27 23
AMIODARONE HCL 68 58 27 166
PROAIR HFA 64 35 30 61
GLIPIZIDE XL 64 52 30 125
HYDRALAZINE HCL 63 56 32 48
TAMSULOSIN HCL 62 45 33 31
NEXIUM 62 43 33 41
ALLOPURINOL 57 53 35 49
METFORMIN HCL ER 55 40 36 80
GABAPENTIN 55 28 36 17
CYCLOBENZAPRINE HCL 54 25 R 38 93
ADVAIR DISKUS 52 34 39 46
PLAVIX 52 41 39 47
DONEPEZIL HCL 52 52 39 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.